Plasma levels of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1a(6-
Vasoconstrictive substances such as histamine, vasopressin and the extracts from prostatic secretion (prostaglandins or vesiglandins), were known as early as the 1930s (von Euler, 1936) to possess contractile effects on smooth muscle of the arteries.
However, the contractile action of thromboxane A2 (TXA2), which was discovered in 1975, was reported to be more striking (Hamberg et al., 1975; Svensson et al. 1977) . On the other hand, no effective naturally occuring dilators were known until prostacyclin was discovered in 1976 (Moncada et al., 1976) . Prostacyclin closely resembles primary prostaglandin, or prostaglandin El, but it is about four times as effective in relaxing the arteries. In addition to the OGINO et al. Endocrinol. Japon. April 1985 vasoactive actions of these compounds, prostacyclin, mainly generated in the vessel wall, is a powerful inhibitor of platelet aggregation, whereas TXA2, produced mainly by platelets, has counteracting proaggregation effects. A balance between TXA2 .and prostacyclin evidently regulates the vascular tonus and platelet aggregation in the systemic circulation (Moncada et al., 1979) . It is well established that the impairment of this balance in the arteriolar bed, particularly in the uterus and the kidney, is a characteristic feature of pregnancy induced hypertension (PIH) (Koullapis et al., 1982) .
In the present study, we have assessed the plasma levels of these vasoactive and platelet-aggregation related prostanoids to elucidate various clinical pictures associated with PIH. (Table 1) For P1 period, there was no significant difference between the control and hypertension group TXB2 concentrations, though plasma levels of TXB2 showed a moderate increase in the patients with PIH compared with those of the controls. However, during the P2 period, the TXB2 concentration in plasma showed a significant rise (p<0.005) in the patients with PIH compared with those of the controls.
Regarding plasma levels of 6-keto-PGF la, they were lower in the patients with PIH to a slight to moderate degree compared with those of the controls, though no statistical differences were noted.
In contrast to the absolute values for each prostanoid in the circulation, it is (Pritchard et al., 1976) , whereby the platelet count is reduced remarkably in association with activation of the fibrinolytic system. In fact, the patients with PIH studied showed a moderate elevation of fibrin degraded products (>15 prostanoid, or TXA2, exerts its physiological effects predominantly at the levels of uterus and the kidney (Koullapis et al., 1982) in the patients with PIH. In this aspect, a moderate to significant elevation of TXA2 in the maternal circulation may well reflect locally occurring vasoconstriction and platelet aggregation, leading to additional renal symptoms. It is worth noting that platetet aggregation elicited by adenosine diphosphate in vitro is remarkably reduced regardless of platelet activation, which reflects an increased generation of TXA2 (Sakamoto, 1983) . This evident discrepancy needs further explanation. One possible explanation is that platelet activation may deleted number of platelets, which in turn facilitates platelet turnover resulting in macrothrombocytosis (Garg et al., 1972; Paulus, 1975) . Therefore, decreased aggregation by adenosine diphosphate in vitro might result from exhaustion (Sakamoto, 1983) and/or shortened life-span of viable platelets regardless of the facilitated platelet turnover.
Regarding the absolute concentrations of TXB2 and 6-keto-PGF 1 a in human plasma, of pregnant or non-pregnant subjects, they vary greatly among the institutions. The plasma levels of TXB2 showed a great difference from a single picogram (Granstrom et al., 1984) to hundreds of picograms (Ylikorkala et al., 1984) per milliliter. Moreover, that of 6-keto-PGF 1 a in pregnant women has been reported to be in the magnitude ranging from double picogram (Mitchell et al., 1978) . to hundreds of picograms (Ylikorkala et al., 1983) per milliliter. The remarkable variation in the absolute assay values among laboratories would depend on the differences, including 1) whether using fresh plasma or frozen plasma, 2) whether the extraction procedure is started soon or late, 3) how the extracted materials are kept, 4) what kinds of separation methods are used, silic acid column chromatography or HPLC, and 5) what kinds of assay methods are applied, GC-MS quan- 
